Shanghai ZJ Bio-Tech CoSHSE:688317 -3.76%69 Days Payable is 628.53 as of Mar. 2026, which is 247% above its 10-year median of 181.34. GuruFocus rates SHSE:688317 with a GF Score™ of 69/100 and a GF Value™ of ¥9.93 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Shanghai ZJ Bio-Tech Co ranks better than 93.21% on this metric.
The historical rank and industry rank for Shanghai ZJ Bio-Tech Co's Days Payable or its related term are showing as below:
SHSE:688317'
s Days Payable Range Over the Past 10 Years
Min: 66.29 Med: 181.34 Max: 835.91
Current: 562.52
During the past 13 years, Shanghai ZJ Bio-Tech Co's highest Days Payable was 835.91. The lowest was 66.29. And the median was 181.34.
SHSE:688317's Days Payable is ranked better than 93.21% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs SHSE:688317: 562.52
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688317 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Shanghai ZJ Bio-Tech Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai ZJ Bio-Tech Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai ZJ Bio-Tech Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Shanghai ZJ Bio-Tech Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Shanghai ZJ Bio-Tech Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai ZJ Bio-Tech Co (SHSE:688317) has a Days Payable of 628.53 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. This is 247% above median its historical median of 181.34. Over the past decade, Shanghai ZJ Bio-Tech Co's Days Payable has ranged from 66.29 to 835.91. According to the industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #54 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 6.8%.
Is Shanghai ZJ Bio-Tech Co's Days Payable too high?
Shanghai ZJ Bio-Tech Co's current Days Payable of 628.53 is 247% above median its 10-year median of 181.34. Over the past 10 years, this metric has ranged from a low of 66.29 to a high of 835.91. The Medical Devices & Instruments industry median Days Payable is 67.87. Shanghai ZJ Bio-Tech Co's value of 628.53 is 826.1% above this industry median. Based on the distribution chart, Shanghai ZJ Bio-Tech Co ranks #54 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai ZJ Bio-Tech Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai ZJ Bio-Tech Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #54 out of 795 companies for Days Payable. This places Shanghai ZJ Bio-Tech Co in the top 7% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Shanghai ZJ Bio-Tech Co's value of 628.53 is 826.1% above this benchmark. Historically, Shanghai ZJ Bio-Tech Co's own Days Payable has ranged from 66.29 to 835.91 over the past decade. While the company's 10-year median is 181.34 vs. the industry median of 67.87, Shanghai ZJ Bio-Tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai ZJ Bio-Tech Co's current Days Payable of 628.53 is 826.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai ZJ Bio-Tech Co's current Days Payable is 628.53, which is 247% above median its own 10-year median of 181.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai ZJ Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co (SHSE:688317) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.93, compared to a current price of ¥15.09 — trading 52% above its estimated fair value. The current Days Payable is 628.53, which is 247% above median its 10-year median of 181.34 and 826.1% above the Medical Devices & Instruments industry median of 67.87. Shanghai ZJ Bio-Tech Co's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shanghai ZJ Bio-Tech Co (SHSE:688317), the current Days Payable is 628.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai ZJ Bio-Tech Co (SHSE:688317) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co stock appears to be overvalued.
The current stock price of ¥15.09 is trading 52% above its estimated GF Value™ of ¥9.93.
GuruFocus considers Shanghai ZJ Bio-Tech Co to be Significantly Overvalued.
Key valuation signals for SHSE:688317:
Days Payable: 628.53 (247% above median its 10-year median of 181.34)
GF Value™: ¥9.93 vs. price of ¥15.09 (52% above fair value)
Industry Position: 826.1% above the Medical Devices & Instruments median (#54 of 795)
No single metric tells the full story. See the SHSE:688317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
69GF Score
Get the complete analysis for SHSE:688317
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688317 has been successfully added to your 
